Patents Assigned to THE ROGOSIN INSTITUTE, INC.
  • Method for isolating a chemotherapeutic agent resistant cancer cell with stem cell properties
    Patent number: 9375448
    Abstract: The invention relates to the use of encapsulates of cancer cells, in agarose coated, agarose containing beads, for isolating chemotherapeutic resistant cells which have at least one stem cell property, such as expression of OCT4. The cells thus isolated are also a feature of the invention, as is a method for screening for potential therapeutic agents.
    Type: Grant
    Filed: April 25, 2014
    Date of Patent: June 28, 2016
    Assignee: THE ROGOSIN INSTITUTE, INC.
    Inventors: Lawrence Gazda, Barry Smith
  • METHOD FOR ISOLATING A CHEMOTHERAPEUTIC AGENT RESISTANT CANCER CELL WITH STEM CELL PROPERTIES
    Publication number: 20140234440
    Abstract: The invention relates to the use of encapsulates of cancer cells, in agarose coated, agarose containing beads, for isolating chemotherapeutic resistant cells which have at least one stem cell property, such as expression of OCT4.
    Type: Application
    Filed: April 25, 2014
    Publication date: August 21, 2014
    Applicant: THE ROGOSIN INSTITUTE, INC.
    Inventors: Lawrence GAZDA, Barry SMITH
  • Method for isolating a chemotherapeutic agent resistant cancer cell with stem cell properties
    Patent number: 8741637
    Abstract: The invention relates to the use of encapsulates of cancer cells, in agarose coated, agarose containing beads, for isolating chemotherapeutic resistant cells which have at least one stem cell property, such as expression of OCT4. The cells thus isolated are also a feature of the invention, as is a method for screening for potential therapeutic agents.
    Type: Grant
    Filed: November 22, 2011
    Date of Patent: June 3, 2014
    Assignee: The Rogosin Institute, Inc.
    Inventors: Lawrence Gazda, Barry Smith
  • METHOD FOR ISOLATING A CHEMOTHERAPEUTIC AGENT RESISTANT CANCER CELL WITH STEM CELL PROPERTIES
    Publication number: 20130244248
    Abstract: The invention relates to the use of encapsulates of cancer cells, in agarose coated, agarose containing beads, for isolating chemotherapeutic resistant cells which have at least one stem cell property, such as expression of OCT4.
    Type: Application
    Filed: November 22, 2011
    Publication date: September 19, 2013
    Applicant: THE ROGOSIN INSTITUTE, INC.
    Inventors: Lawrence Gazda, Barry Smith